Dr. Jamie Cesaretti, MD

Dr. Jamie Cesaretti, MD

Radiation Oncology  |  
Male  |  
Age 47
(193)
Insurances AcceptedSave
Dr. Jamie Cesaretti, MD is a radiation oncology specialist in Jacksonville, FL and has been practicing for 14 years. He graduated from State University Of New York At Stony Brook in 1999 and specializes in radiation oncology, gastrointestinal oncology, and more.

7017 A C Skinner Pkwy

Jacksonville, FL 32256

Contact Information

Insurance Accepted

  • Accepts most major Health Plans. Please contact our office for details.
  • Aetna
  • Blue Cross Blue Shield
  • Cigna
  • First Health (Coventry Health Care)
  • Humana
  • Medicaid
  • UnitedHealthCare

*Please verify this information when scheduling an appointment.

Learn about Dr. Cesaretti

Be confident in your decisions by checking out your provider's top areas of care, education, patient reviews and more. Learn about finding the right doctor for you

Top Care Areas

new

See how frequently Dr. Cesaretti performs your care needs compared to other doctors.

Prostate Cancer
very high
more than 99% of peers
Urinary Disorders
very high
more than 99% of peers
Cancer
very high
more than 97% of peers

Dr. Cesaretti's percentages are based on the rate of treatment compared to peers nationwide from insurance data. Learn more info about our data and this Top Care Areas component.

We're trying something new with Top Care Areas.Was it helpful for you?YesNo

Care Philosophy

This content was provided by Dr. Cesaretti "He also has a particular interest in helping patients with cancer make the right personal decision regarding their cancer care among an often-overwhelming array of potential treatment choices."
5

Specialties

  • Radiation Oncology
  • Gastrointestinal Oncology
  • Geriatric Oncology
  • Integrative Oncology
  • Prostate Oncology
1

Board Certifications

  • Radiation Oncology
    Accredited by: American Board of Radiology*
23

Conditions Treated

4

Procedures

Background Check

0 Malpractice Claims

No malpractice history found for Florida.

0 Sanctions

No sanctions history found for the years that Healthgrades collects data.

0 Board Actions

No board actions found for the years that Healthgrades collects data.

Education

  • Columbia University / College Of Physicians and Surgeons
    Undergraduate School | Graduated 1993
  • State University Of New York At Stony Brook
    Medical School | Graduated 1999
  • St. Lukes-Roosevelt Hospital
    Internship Hospital | Completed 2000
  • Mt Sinai School Of Med
    Residency Hospital | Completed 2004
  • Mount Sinai School Of Medicine
    Other Education | Completed 2006

Awards & Recognition

Awards & Honors
  • Healthgrades Honor Roll
  • Most Compassionate Doctor, 1/1/2011
  • Best Doctors 2011-2012, 1/1/2011
Media & Publications
  • Prostate brachytherapy preserves erectile function, Aug 2007
  • Radiotherapy planning complexity and survival after treatment of advanced stage lung cancer in the elderly, 2009 June
  • Effect of Radiotherapy Planning Complexity on Survival of Elderly Patients with Unresected Localized Lung Cancer, 2010 Oct
  • Genetic predictors of adverse radiotherapy effects: the Gene-PARE project, 2006 Jul 1
  • Brachytherapy for Prostate Cancer, 2007 Sept
  • Radiosurgery for Thoracic Malignancies, 2008 Feb
  • Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response, 2009 Aug
  • Does Neoadjuvant Hormonal Therapy Improve Urinary Function When Given to Men With Large Prostates Undergoing Prostate Brachytherapy?, 2009 Dec
  • Acceptability and preliminary feasibility of an internet/CD-ROM-based education and decision program for early-stage prostate cancer patients: randomized pilot study, 2012 Jan
  • Update on Prostate Brachytherapy: Long-term Outcomes and Treatment-related Morbidity., June 2011
  • Urinary Morbidity Following Post-brachytherapy Transurethral Resection of the Prostate, 2005 Mar
  • ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy, 2006 Mar 1
  • Biologically effective dose values for prostate brachytherapy: Effects on PSA failure and post-treatment biopsy results, 2006 Feb 1
  • Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: analysis at 7 years of follow-up, 2007 Aug
  • Combined Modality Treatment in the Management of High Risk Prostate Cancer, 2004 Aug 1
  • Brachytherapy. Book Chapter, Prostate Cancer: Principles and Practice, Ed by Kirby R, Partin AW, Feneley M, Parsons JK, 1/2005
  • Changing the patterns of failure for high-risk prostate cancer patients by optimizing local control, 2006 Oct
  • Possession of ATM Sequence Variants as Predictor for Late Normal Tissue Responses in Breast Cancer Patients Treated with Radiotherapy, 2007 May 1
  • Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancer., Aug 2010
  • Phase II Trial of Concurrent Sunitinib and Image-Guided Radiotherapy for Oligometastases, 2012 Jun
  • Radiation Dose Predicts for Biochemical Control in Intermediate-Risk Prostate Cancer Patients Treated with Low-Dose-Rate Brachytherapy, 2009 Mar
  • There is No Correlation Between Erectile Dysfunction and Dose to Penile Bulb and Neurovascular Bundles Following Real-Time Low-Dose Rate Prostate Brachytherapy, 2009 Apr
  • (125)I monotherapy using D90 implant doses of 180 Gy or greater, 2008 Jan
  • A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy, 2007 May 8
  • Is seminal vesicle implantation with permanent sources possible? A dose-volume histogram analysis in patients undergoing combined 103Pd implantation and external beam radiation for T3c prostate cancer, 2007 Jan
  • Early use of a phosphodiesterase inhibitor after brachytherapy restores and preserves erectile function, 2006 Dec
  • ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy, 2006 Mar
  • ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer, 2005 Jan 1
  • Local Control Following Permanent Prostate Brachytherapy: Effect of High Biologically Effective Dose on Biopsy Results and Oncologic Outcomes, 2009 Jul
  • Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications, 2003 Jun 1
  • Do high radiation doses in locally advanced prostate cancer patients treated with (103)Pd implant plus external beam irradiation cause increased urinary, rectal, and sexual morbidity?, 2009 Oct
  • Prognostic Significance of 5-Year PSA Value for Predicting Prostate Cancer Recurrence After Brachytherapy Alone and Combined with Hormonal Therapy and/or External Beam Radiotherapy, 2008 Dec
  • Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer, 2008 Jul
  • Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma, 2008 Feb
  • Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFS, 2007 Jan
  • Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation, 2006 Nov
  • Brachytherapy for patients with inflammatory bowel disease, 2006 Oct 1
  • Disease-specific survival following the brachytherapy management of prostate cancer, 2006 Mar 1
  • Johns Hopkins Textbook of Prostate Cancer Treatment, 2008
  • Does neoadjuvant hormonal therapy improve urinary function when given to men with large prostates undergoing prostate brachytherapy?, Feb 2010
  • Urinary symptom flare following I-125 prostate brachytherapy, 2003 Jul 1
  • Does a prior transurethral resection of the prostate compromise brachytherapy quality: a dosimetric analysis, 2004 Oct 1
  • TGFB1 Single Nucleotide Polymorphisms are Associated with Adverse Quality of Life in Prostate Cancer Patients Treated with Radiotherapy, 2007 Aug
  • Distant and local recurrence in patients with biochemical failure after prostate brachytherapy, 2009 Apr
  • Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy, 2009 Jun

Languages Spoken

  • English
  • Spanish

Memberships & Professional Affiliations

Dr. Cesaretti does not have any memberships or affiliations listed. If you are Dr. Cesaretti and would like to add memberships or affiliations, please update your profile.

Dr. Cesaretti's Reviews

Likelihood of recommending Dr. Cesaretti to family and friends
5.0
based on 193 total reviews (51 with comments)

Likelihood to Recommend (193)

  • 5
    (191)
  • 4
    (2)
  • 3
    (0)
  • 2
    (0)
  • 1
    (0)

Dr. Cesaretti's Performance

Trustworthiness
EXCELLENT
Explains condition(s) well
EXCELLENT
Answers Questions
EXCELLENT
Time well spent
EXCELLENT

Office & Staff Performance

Scheduling
EXCELLENT
Office environment
EXCELLENT
Staff friendliness
EXCELLENT
Average wait time
Under 10 minutes

Patient Comments (51)

Competent, caring, calming. Dr. Cesaretti is the best. I wouldn't consider going to anyone else for treatment.
Was this helpful? YESNot Helpful
Flag this
This has been the best experience of my life in my time of need. Best staff anywhere!
Was this helpful? YESNot Helpful
Flag this
Everyone was great, they were very supportive and positive. I was treated like a person, not a number.
Was this helpful? YESNot Helpful
Flag this
Thank you so much for making a difficult situation much, much, better. We appreciate you so very much.
Was this helpful? YESNot Helpful
Flag this
Excellent experience!
Was this helpful? YESNot Helpful
Flag this

Are you Dr. Cesaretti?
Make it easy for patients to share their feedback. Also manage your personalized profile!